Matrix metalloproteinase-2 (MMP-2) is constitutively expressed in vascular smooth muscle cells (VSMCs). Using small interfering RNA (siRNA), we evaluated the effect of MMP-2 inhibition in VSMCs in vitro and ex vivo. Rabbit VSMCs were transfected in vitro with 50 nmol/l MMP-2 siRNA or scramble siRNA. Flow cytometry and confocal microscopy showed cellular uptake of siRNA in approximately 80% of VSMCs. MMP-2 mRNA levels evaluated by real-time RT-PCR, pro-MMP-2 activity from conditioned culture media evaluated by gelatin zymography, and VSMC migration were reduced by 44 +/- 19%, 43 +/- 14%, and 36 +/- 14%, respectively, in MMP-2 siRNA-transfected compared with scramble siRNA-transfected VSMCs (P < 0.005 for all). Ex vivo MMP-2 siRNA transfection was performed 2 wk after balloon injury of hypercholesterolemic rabbit carotid arteries. Fluorescence microscopy showed circumferential siRNA uptake in neointimal cells. Gelatin zymography of carotid artery culture medium demonstrated a significant decrease of pro-MMP-2 activity in MMP-2 siRNA-transfected compared with scramble siRNA-transfected arteries (P < 0.01). Overall, our results demonstrate that in vitro MMP-2 siRNA transfection in VSMCs markedly inhibits MMP-2 gene expression and VSMC migration and that ex vivo delivery of MMP-2 siRNA in balloon-injured arteries reduces pro-MMP-2 activity in neointimal cells, suggesting that siRNA could be used to modify arterial biology in vivo.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1152/ajpheart.00517.2007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mechanism of HIF-1α promoting proliferation, invasion and metastasis of nasopharyngeal carcinoma by regulating MMP-2 in hypoxic microenvironment.
Heliyon
December 2024
Department of Trauma Orthopedic and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Objective: To explore the mechanism of HIF-1α promoting the proliferation, invasion and metastasis of nasopharyngeal carcinoma cells by regulating the expression of MMP-2.
Methods: 30 nasopharyngeal carcinoma tissues and 30 normal nasopharyngeal epithelial tissues were collected, and the expression of HIF-1α and MMP-2 in the nasopharyngeal carcinoma, normal nasopharyngeal epithelial tissues and their hypoxic environment were systematically analyzed by qRT-PCR and western blot techniques. Lentivirus transfection technology was used to regulate the expression of HIF-1α and MMP-2 genes in the HONE1 cell line under hypoxic environment, and to explore the interaction mechanism of HIF-1α and MMP-2 genes and their role in the proliferation, invasion and metastasis of nasopharyngeal carcinoma.
Hypoglycemic Agents Increase Regulatory Factor X1 to Inhibit Cancer Cell Behaviour in Human Glioblastoma Cells.
J Cell Mol Med
December 2024
Department of Anesthesiology, University of Virginia, Charlottesville, Virginia, USA.
Article Synopsis
- Glioblastoma multiforme is a highly aggressive brain tumor, and research has found that the transcription factor RFX1 can inhibit the growth and spread of these tumor cells.
- The study identified existing medications that could boost RFX1 levels in glioblastoma cells, using bioinformatics and laboratory testing, confirming that drugs like pioglitazone and rosiglitazone effectively promote RFX1.
- These hypoglycemic medications were shown to decrease cancer cell proliferation and invasion, primarily by reducing metalloproteinase 2 (MMP2) activity, making RFX1 a potential therapeutic target for glioblastoma treatment.
Metformin inhibits migration and epithelial-to-mesenchymal transition in non-small cell lung cancer cells through AMPK-mediated GDF15 induction.
Eur J Pharmacol
December 2024
School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 311400, China. Electronic address:
The growth differentiation factor 15 (GDF15) may serve as a biomarker of metformin, which mediates the bodyweight lowering effect of metformin. However, whether GDF15 also serves as a molecular target of metformin to inhibit carcinogenesis remains largely unknown. This study examined the role and molecular mechanisms of GDF15 in the anticancer effects of metformin in non-small cell lung cancer (NSCLC) cells, which has never been reported before.
View Article and Find Full Text PDFMMP-2 Responsive Gold Nanorods Loaded with HSP-70 siRNA for Enhanced Photothermal Tumor Therapy.
Mol Pharm
November 2024
School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China.
Article Synopsis
- Gold nanorods (Au NRs) show potential in tumor therapy through photothermal effects, but increased heat shock proteins in tumor cells can lead to heat resistance, reducing their effectiveness.
- A novel delivery system called AGC/HSP-70 siRNA was developed to inhibit heat shock protein 70 (HSP-70) expression using RNA interference, which enhances the photothermal therapy by allowing better penetration and accumulation of the treatment in tumors.
- Experimental results demonstrated that the AGC/HSP-70 siRNA platform significantly improved the photothermal therapeutic effects of Au NRs, suggesting its potential as an effective strategy for cancer treatment.
PDCD4 promotes inflammation/fibrosis by activating the PPAR‑γ/NF‑κB pathway in mouse atrial myocytes.
Mol Med Rep
November 2024
School of Health Management, Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China.
Fibrosis is the basis of structural remodeling in atrial fibrillation (AF), during which inflammation is crucial. Programmed cell death factor 4 (PDCD4) is a newly identified inflammatory gene, with unknown mechanisms of action in AF. The present study aimed to elucidate the effects of PDCD4 on the inflammation and structural remodeling of atrial myocytes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!